Abstract
In this issue of Blood, Bartlett et al share their experience with the use of ibrutinib in patients with relapsed or refractory follicular lymphoma (FL).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 156-157 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 131 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 11 2018 |
| Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology